UK markets open in 4 hours 22 minutes
NIKKEI 225
38,091.46 -314.20 (-0.82%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.09 -0.84 (-1.03%) GOLD FUTURES
2,297.90 -5.00 (-0.22%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,796.18 -3,269.23 (-6.40%)
Mereo BioPharma Group plc (MREO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 387.15M |
| Enterprise value | 335.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 36.40 |
| Price/book (mrq) | 7.66 |
| Enterprise value/revenue | 33.57 |
| Enterprise value/EBITDA | -12.88 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.78 |
| 52-week change 3 | 145.97% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 4.3600 |
| 52-week low 3 | 0.9200 |
| 50-day moving average 3 | 3.2022 |
| 200-day moving average 3 | 2.3168 |
Share statistics
| Avg vol (3-month) 3 | 1.26M |
| Avg vol (10-day) 3 | 863.56k |
| Shares outstanding 5 | 140.27M |
| Implied shares outstanding 6 | 140.24M |
| Float 8 | 312.54M |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 61.47% |
| Shares short (15 Apr 2024) 4 | 2.77M |
| Short ratio (15 Apr 2024) 4 | 2.59 |
| Short % of float (15 Apr 2024) 4 | 2.38% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.97% |
| Shares short (prior month 15 Mar 2024) 4 | 2.19M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -294.66% |
| Operating margin (ttm) | -1,576.50% |
Management effectiveness
| Return on assets (ttm) | -23.57% |
| Return on equity (ttm) | -57.81% |
Income statement
| Revenue (ttm) | 10M |
| Revenue per share (ttm) | 0.08 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -26.57M |
| Net income avi to common (ttm) | -29.47M |
| Diluted EPS (ttm) | -0.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 57.42M |
| Total cash per share (mrq) | 0.08 |
| Total debt (mrq) | 5.95M |
| Total debt/equity (mrq) | 11.78% |
| Current ratio (mrq) | 6.72 |
| Book value per share (mrq) | 0.36 |
Cash flow statement
| Operating cash flow (ttm) | -21.13M |
| Levered free cash flow (ttm) | -14.17M |
© 2024 Yahoo. All rights reserved.